In a significant development for India's oncology landscape, Elekta, a global leader in precision radiation medicine, unveiled its groundbreaking AI-powered EVO online adaptive CT Linac at a major medical conference in the country's northeast. The showcase took place at the Association of Medical Physicists of India National Congress 2025 (AMPICON), held in Guwahati, Assam.
A Leap Forward in Adaptive Radiotherapy Technology
The EVO system represents a paradigm shift in radiation therapy delivery. It integrates advanced artificial intelligence with real-time imaging to create a highly precise and personalized treatment platform. Unlike traditional linear accelerators (linacs), the EVO system features an integrated computed tomography (CT) scanner. This allows clinicians to capture detailed images of the tumor and surrounding healthy tissues immediately before each treatment session.
The core innovation lies in its online adaptive workflow. Using AI algorithms, the system can analyze the new CT scan and compare it to the original planning scan. It then automatically adapts the radiation treatment plan in minutes to account for day-to-day changes in the patient's anatomy, such as tumor shrinkage or organ movement. This capability ensures the radiation dose is delivered with exceptional accuracy, maximizing the impact on cancer cells while minimizing exposure to healthy tissue.
Spotlight on Guwahati: A Strategic Showcase
The choice of Guwahati as the venue for this unveiling is strategic, highlighting the growing emphasis on bringing cutting-edge cancer care technology to all regions of India. The AMPICON 2025 congress, a premier event for medical physicists, provided the perfect platform to demonstrate EVO's capabilities to the professionals who are critical in implementing and managing such advanced radiotherapy solutions in hospitals.
Elekta's participation underscores its commitment to the Indian market, where the burden of cancer is rising. By introducing online adaptive radiotherapy technology, the company aims to empower Indian oncology centers to offer more effective and safer treatments. The system's efficiency in re-planning could also potentially increase patient throughput, a vital factor for high-volume cancer centers across the nation.
Implications for the Future of Cancer Treatment in India
The introduction of the EVO system at AMPICON 2025 signals a new chapter for radiation oncology in India. The integration of AI for real-time plan adaptation addresses a long-standing challenge in treatment precision. For patients, this translates to potentially better clinical outcomes, fewer side effects, and a higher quality of life during and after therapy.
For the medical community, particularly medical physicists and radiation oncologists, tools like the Elekta EVO CT Linac enhance their ability to practice precision medicine. The showcase in Guwahati is likely a precursor to wider adoption in Indian healthcare institutions, aiming to bridge technological gaps and set new standards for cancer care. This move aligns with broader national health goals to improve access to advanced and affordable oncology treatments, bringing world-class technology to the doorstep of patients in every corner of the country.
As the congress concluded, the demonstration of EVO left a strong impression, pointing towards a future where AI-driven adaptive radiotherapy becomes a cornerstone in the fight against cancer in India.
